Clinical Trial Update: CD155 in Bladder Cancer

View source ↗

Summary

A clinical trial evaluating CD155 in bladder cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Snippet

Sponsor: Fudan University | Conditions: Bladder Cancer | Status: COMPLETED